Nonheme iron catalyst mimics heme-dependent haloperoxidase for efficient bromination and oxidation.

Zhao, Guodong; Dong, Huiling; Xue, Kang; Lou, Shaoyan; Qi, Rui; Zhang, Xiaohui; Cao, Zhuo; Qin, Qi et al. · Sci Adv · 2024

basic_science · Level V

Where this comes from

Abstract

The [Fe]/H<sub>2</sub>O<sub>2</sub> oxidation system has found wide applications in chemistry and biology. Halogenation with this [Fe]/H<sub>2</sub>O<sub>2</sub> oxidation protocol and halide (X<sup>-</sup>) in the biological system is well established with the identification of heme-iron-dependent haloperoxidases. However, mimicking such halogenation process is rarely explored for practical use in organic synthesis. Here, we report the development of a nonheme iron catalyst that mimics the heme-iron-dependent haloperoxidases to catalyze the generation of HOBr from H<sub>2</sub>O<sub>2</sub>/Br<sup>-</sup> with high efficiency. We discovered that a tridentate terpyridine (TPY) ligand designed for Fenton chemistry was optimal for FeBr<sub>3</sub> to form a stable nonheme iron catalyst [Fe(TPY)Br<sub>3</sub>], which catalyzed arene bromination, Hunsdiecker-type decarboxylative bromination, bromolactonization, and oxidation of sulfides and thiols. Mechanistic studies revealed that Fenton chemistry ([Fe]/H<sub>2</sub>O<sub>2</sub>) might operate to generate hydroxyl radical (HO<sup>•</sup>), which oxidize bromide ion [Br<sup>-</sup>] into reactive HOBr. This nonheme iron catalyst represents a biomimetic model for heme-iron-dependent haloperoxidases with potential applications in organic synthesis, drug discovery, and biology.

Medical subject headings